News Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 22, 2024
BEDFORD, Mass. — November 22, 2024 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that senior management will...
-
Oct 31, 2024Updating 2024 fiscal year guidance to reflect announced changes to business strategy, including the sale of Arthrosurface and planned divestiture of Parcus Medical, and U.S. OA Pain Management headwinds
BEDFORD, Mass., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results...
-
Oct 31, 2024Company to Focus on Profitable Hyaluronic Acid-Driven OA Pain Management and High Growth Regenerative Solutions Portfolio, Streamline Operations and Enhance Growth Profile
Company to Focus on Profitable Hyaluronic Acid-Driven OA Pain Management and High Growth Regenerative Solutions Portfolio, Streamline Operations and Enhance Growth Profile BEDFORD, Mass., Oct. 30,...
-
Oct 17, 2024
BEDFORD, Mass., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue...
-
Oct 4, 2024
BEDFORD, Mass., October 4 , 2024 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on October 1, 2024, Anika...
-
Sep 9, 2024
BEDFORD, Mass., September 9, 2024 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on September 3, 2024,...
-
Aug 15, 2024
BEDFORD, Mass., August 15, 2024 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on August 1, 2024, Anika...
-
Aug 8, 2024
Expanded Regenerative Solutions portfolio with full market release of the Integrity™ Implant System, a hyaluronic acid (HA)-based scaffold for rotator cuff and other tendon repairs, generating...
-
Aug 5, 2024
BEDFORD, Mass. — August 5, 2024 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will...
-
Jul 25, 2024
BEDFORD, Mass., July 25, 2024 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its...
-
Jul 11, 2024
BEDFORD, Mass., July 11, 2024 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on July 1, 2024, Anika...
-
Jul 11, 2024Integrity and its complete arthroscopic instrumentation platform are now fully available in the U.S., expanding Anika’s proprietary hyaluronic acid (HA) regenerative portfolio
Integrity and its complete arthroscopic instrumentation platform are now fully available in the U.S., expanding Anika’s proprietary hyaluronic acid (HA) regenerative portfolio Over 300 surgeries...
-
Jun 7, 2024
BEDFORD, Mass., June 7, 2024 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on June 3, 2024, Anika...
-
May 28, 2024
Appoints Joseph Capper and William Jellison to Board of Directors Announces New $40 Million Share Repurchase Program BEDFORD, Mass., May 28, 2024 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a...
-
May 8, 2024
Steve Griffin Appointed Chief Financial Officer, Effective June 3, 2024 BEDFORD, MASS., May 8, 2024 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early...
-
May 8, 2024
Revenue up 7% on growing demand and favorable order timing; On-track for 2024 revenue guidance Cost reduction initiatives complete; On-track to achieve 2024 adjusted EBITDA guidance of $25-30...
-
May 3, 2024
BEDFORD, Mass., May 3, 2024 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on May 1, 2024, Anika granted...
-
Apr 18, 2024
BEDFORD, Mass., April 18, 2024 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue...
-
Apr 2, 2024
BEDFORD, Mass. — April 2, 2024 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will...
-
Mar 13, 2024
BEDFORD, Mass., March 13, 2024 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for its...
-
Mar 8, 2024
BEDFORD, Mass., March 8, 2024 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on March 1, 2024, Anika...
-
Feb 27, 2024
BEDFORD, Mass., February 27, 2024 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue...
-
Feb 13, 2024
Announcing the limited market release of X-TwistÔ Fixation System with biocomposite suture anchor for rotator cuff and other soft tissue repair at AAOS Focusing on its full Regenerative, Sports...
-
Nov 28, 2023
Integrity marks Anika’s entrance into the fast-growing $150 million+2 U.S. rotator cuff augmentation market and expansion of its proprietary hyaluronic acid (HA) regenerative portfolio BEDFORD,...
-
Nov 7, 2023
BEDFORD, Mass., November 7, 2023 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard,...
-
Nov 2, 2023
Revenue Growth Exceeded Expectations in the Third Quarter and Year-To-Date, with Joint Preservation and Restoration up 14% and 10% and OA Pain Management up 2% and 11%, Respectively RevoMotion™...
-
Oct 10, 2023
BEDFORD, Mass., October 10, 2023 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue...
Sep 19, 2023RevoMotion Reverse Shoulder Arthroplasty System significantly expands Anika’s shoulder arthroplasty portfolio and provides a bone conserving and innovative solution in the $1 billion1 U.S. reverse shoulder marketRevoMotion Reverse Shoulder Arthroplasty System significantly expands Anika’s shoulder arthroplasty portfolio and provides a bone conserving and innovative solution in the $1 billion1 U.S....
-
Sep 15, 2023
BEDFORD, Mass., September 15, 2023 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on September 5, 2023,...
-
Sep 12, 2023
BEDFORD, Mass. — September 12, 2023 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will...
-
Aug 17, 2023Complete Integrity Implant System is now fully cleared; targeting launch in Q1-2024
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that it has received the...
-
Aug 8, 2023
Double Digit Q2 Revenue Growth Driven by Strong OA Pain Management Growth of 22%; Raising Low-End of Full-Year Guidance Range on Positive Year-to-Date Performance Hyalofast®, Single-Stage,...
-
Jul 20, 2023
BEDFORD, Mass., July 20, 2023 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its...
-
Jul 12, 2023
Anika’s new X-Twist™ Fixation System, combined with its ACE Award-Winning Tactoset® for hardware augmentation and autologous bone morrow aspirate, provide time-saving regenerative solutions...
-
May 30, 2023
Hyalofast – a single-stage, off-the-shelf, resorbable, hyaluronic acid scaffold for cartilage repair is marketed in over 35 countries outside the U.S. where it has been clinically demonstrated...
-
May 9, 2023Positive Start to 2023 Revenue Growth with OA Pain Management Up 8% and Joint Preservation and Restoration Up 11%
BEDFORD, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results...
-
Apr 19, 2023
BEDFORD, Mass., April 19, 2023 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue...
-
Apr 13, 2023Gary Fischetti Joins Anika Board
Bedford, Mass., April 13, 2023 – Anika Therapeutics, Inc. (NASDAQ: ANIK) (“Anika” or the “Company”), a global joint preservation company in early intervention orthopedics, today...
-
Apr 12, 2023
BEDFORD, Mass. — April 12, 2023 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will...
-
Apr 3, 2023Tactoset cleared by the FDA to be combined with autologous bone marrow aspirate, a core element for regenerative healing
BEDFORD, Mass., April 3, 2023 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that it has received an...
-
Mar 27, 2023
BEDFORD, Mass., March 27, 2023 – Anika Therapeutics, Inc. (NASDAQ: ANIK) (“Anika” or the “Company”), a global joint preservation company in early intervention orthopedics, today...
-
Mar 15, 2023
BEDFORD, Mass. — March 15, 2023 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will...
-
Mar 8, 2023Recently Commenced Full Market Release of X-Twist™ Fixation System, a Cornerstone Product in Anika’s Sports Medicine Portfolio
BEDFORD, Mass., March 8, 2023 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company, today announced it is highlighting recently-launched products in high growth segments...
-
Mar 6, 2023Delivered Fourth Quarter Revenue Growth of 11% and Full Year 2022 Revenue Growth of 6%
BEDFORD, Mass., March 6, 2023 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for its fourth...
-
Feb 28, 2023
BEDFORD, Mass. — February 28, 2023 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will...
-
Feb 21, 2023
BEDFORD, Mass., February 21, 2023 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue...
-
Feb 21, 2023
BEDFORD, Mass., February 21, 2023 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today issued the following statement in...
-
Feb 13, 2023RevoMotion significantly expands Anika’s shoulder arthroplasty portfolio and provides a new solution in the over $800 million U.S. reverse shoulder market
BEDFORD, Mass., February 13, 2023-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that it has commenced...
-
Nov 8, 2022Third Quarter Revenue Growth of 2%
BEDFORD, Mass., November 8, 2022 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for its third...
-
Nov 1, 2022Study Demonstrated Superiority of Cingal, a Single-Injection Hyaluronic Acid-Based Viscosupplement Combined with Fast-Acting Steroid, Over Steroid Alone, for Osteoarthritis Pain Relief at 26 Weeks
BEDFORD, Mass., November 1, 2022 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that Cingal® met its...
-
Oct 25, 2022
BEDFORD, Mass., October 25, 2022 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue...
-
Sep 12, 2022X-Twist expands Anika’s sports medicine portfolio with a cornerstone suture anchor system ideal for key repairs in the shoulder, foot and ankle, and other extremities
BEDFORD, Mass., September 12, 2022-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced the limited market...
-
Aug 3, 2022Second quarter revenue growth up 4%
X-Twist™ 510(k) clearance received; Limited market release on schedule for 2H 2022BEDFORD, Mass., August 3, 2022 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for its second...
-
Jul 27, 2022
BEDFORD, Mass., July 27, 2022 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that it has received the...
-
Jul 12, 2022
BEDFORD, Mass., July 12, 2022 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its...
-
Jun 10, 2022
BEDFORD, Mass. — June 10, 2022 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will...
-
May 20, 2022X-Twist provides a simple, versatile knotless suture anchor system ideal for key repairs in the shoulder, foot and ankle, and other extremities
BEDFORD, Mass., May 19, 2022-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that it has received 510(k)...
-
May 13, 2022
BEDFORD, Mass., May 13, 2022 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on May 2, 2022, Anika granted...
-
May 9, 2022
BEDFORD, Mass. — May 9, 2022 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will participate...
-
May 5, 2022First quarter revenue growth of 7% year-over-year driven by favorable order timing in OA Pain Management
BEDFORD, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results...
-
Apr 15, 2022
BEDFORD, Mass., April 15, 2022 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on April 1, 2022, Anika...
-
Apr 7, 2022
BEDFORD, Mass., April 7, 2022 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its...
-
Apr 4, 2022
BEDFORD, Mass. — April 4, 2022 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will...
-
Mar 23, 2022Anika is an innovative joint preservation company focused on the early intervention orthopedic continuum of care including OA pain management, regenerative solutions, sports medicine, and bone preserving joint technologies.
BEDFORD, Mass., March 23, 2022 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company, today announced it will showcase its comprehensive joint preservation and...
-
Mar 15, 2022
BEDFORD, Mass., March 15, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that it granted:...
-
Mar 10, 2022
BEDFORD, Mass., March 10, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management...
-
Mar 8, 2022Fourth quarter revenue growth of 10% year-over-year despite COVID headwinds
Fourth quarter revenue growth of 10% year-over-year despite COVID headwinds Full-year 2021 revenue up 13% driven by strong growth in Joint Preservation and Restoration BEDFORD, Mass., March 08,...
Feb 11, 2022BEDFORD, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on February...
-
Feb 8, 2022
BEDFORD, Mass., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company...
- Dec 10, 2021
BEDFORD, Mass., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on December...
- Nov 18, 2021
BEDFORD, Mass., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl...
-
Nov 4, 2021Revenue growth of 25% year-over-year
BEDFORD, Mass., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results...
- Nov 1, 2021Appointment brings experienced orthopedic industry commercial leader to Anika’s Board
BEDFORD, Mass., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that its...
- Oct 18, 2021
BEDFORD, Mass., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company...
- Sep 30, 2021Designed to preserve natural motion and maximize stability, the WristMotion® Total Wrist Arthroplasty System provides an advanced solution for wrist arthritis and an alternative to wrist fusion
BEDFORD, Mass., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company, today announced its WristMotion® Total Wrist Arthroplasty (TWA)...
- Sep 14, 2021510(k) clearance expands the capability of Tactoset for augmenting suture anchor fixation
BEDFORD, Mass., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that it...
- Sep 7, 2021
BEDFORD, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that Dr....
- Sep 1, 2021Anika, now combined with Arthrosurface and Parcus Medical, meets the evolving unmet needs of surgeons in the global joint preservation market
BEDFORD, Mass., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, will debut their full...
-
Aug 5, 2021Revenue growth of 24% year-over-year
BEDFORD, Mass., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results...
- Jul 19, 2021
BEDFORD, Mass., July 19, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company...
- Jul 1, 2021WristMotion Total Wrist Arthroplasty limited launch initiated
BEDFORD, Mass., July 01, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced the limited launch...
- Jun 3, 2021Company details multi-year Joint Preservation strategy for accelerated revenue growth and profitability
BEDFORD, Mass., June 03, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today will host its 2021 Virtual...
- May 13, 2021
BEDFORD, Mass., May 13, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company...
-
May 6, 2021Revenue lower by 3% versus pre-COVID in prior year
BEDFORD, Mass., May 06, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results...
- May 4, 2021
BEDFORD, Mass., May 04, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl...
- Apr 15, 2021
BEDFORD, Mass., April 15, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company...
- Apr 5, 2021
BEDFORD, Mass., April 05, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl...
- Mar 11, 2021
BEDFORD, Mass., March 11, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl...
-
Mar 4, 2021Completed Transformative Year with Q4 2020 Revenue Up 10% Year-Over-Year,
BEDFORD, Mass., March 04, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company that creates and delivers meaningful advancements in early...
- Feb 9, 2021
BEDFORD, Mass., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company that creates and delivers meaningful advancements in early...
-
Nov 4, 2020Revenue Increased 7% Year-over-Year to $31.7 Million
BEDFORD, Mass., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company that creates and delivers meaningful advancements in early...
- Oct 22, 2020
BEDFORD, Mass., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company that creates and delivers meaningful advancements in early...
- Oct 21, 2020System designed to alleviate pain and restore function and mobility of the wrist joint
BEDFORD, Mass., Oct. 21, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company that creates and delivers meaningful advancements in early...
- Sep 8, 2020Board Chair Joseph Bower, D.B.A. announces intention not to stand for re-election at 2021 Annual Meeting
BEDFORD, Mass., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation, restoration and regenerative solutions company with products...
- Sep 3, 2020
BEDFORD, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation, restoration and regenerative solutions company with products...
- Aug 5, 2020Seasoned financial executive brings broad medical device industry experience and track record of value creation
BEDFORD, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation, restoration and regenerative solutions company with products...
- Jul 30, 2020Increased Total Revenue 1% Year-over-Year to $30.7 Million
BEDFORD, Mass., July 30, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation, restoration and regenerative solutions company with products...
- Jul 20, 2020Innovative Products Designed to Meet Needs of Surgeons and their Patients in Joint Preservation and Restoration Procedures
BEDFORD, Mass., July 20, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation, restoration and regenerative solutions company with products...
- Jul 16, 2020
BEDFORD, Mass., July 16, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation, restoration and regenerative solutions company with products...
- Jun 2, 2020Sylvia Cheung to Step Down in August 2020
BEDFORD, Mass., June 02, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products across the...